Table 1.
Type 1 cytokines (2, 5) | Type 2 cytokines (7–10) | TNF (12, 15) | IL-1 (11) | IL-17 (13, 14) | |||||
---|---|---|---|---|---|---|---|---|---|
γc | βc | gp130 | IL-12 | Others | IFNs | IL-10 | |||
IL-2 | IL-3 | IL-6 | IL-12 | Growth hormone | IFN-α | IL-10 | TNF | IL-1α | IL-17A |
IL-4 | IL-5 | IL-11 | IL-23 | Prolactin | IFN-β | IL-19 | LTα3 | IL-1β | IL-17B |
IL-7 | GM-CSF | IL-31 | IL-27 | Erythropoietin | IFN-γ | IL-20 | LTα1β2 | IL-1RA | IL-17C |
IL-9 | Oncostatin M | IL-35 | Thrombopoietin | IL-22 | OX40L | IL-18 | IL-17D | ||
IL-15 | Leukemia inhibitory factor | M-CSF | IL-24 | CD40L | IL-33 | IL-17E (IL-25) | |||
IL-21 | Ciliary neurotrophic factor | SCF | IL-26 | RANKL | IL-36α, β, γ | IL-17F | |||
Cardiotropin-1 | TSLP | IL-28Aa | TWEAK | IL-36RA | |||||
NNT-1/BSF-3 | IL-13 | IL-28Ba | APRIL | IL-37 | |||||
Leptin | IL-29a | BAFF | IL-38 | ||||||
G-CSF | LIGHTb |
IL-28A, IL-28B, and IL-29 are also known as type III interferons or IFN-λs.
Homologous to lymphotoxin; exhibits inducible expression and competes with HSV glycoprotein D for binding to herpesvirus entry mediator; a receptor expressed on T lymphocytes.
Abbreviations: APRIL, a proliferation-inducing ligand; BAFF, B cell–activating factor; BSF-3, B cell–stimulating factor 3; CD40L, CD40 ligand; GM-CSF, granulocyte-macrophage colony-stimulating factor; G-CSF, granulocyte colony-stimulating factor; IL-1RA, IL-1 receptor antagonist; IL-36RA, IL-36 receptor antagonist; LTα1β2, lymphotoxin α1β2; LTα3, lymphotoxin α3; M-CSF, macrophage colony-stimulating factor; NNT-1, novel neurotrophin 1; SCF, stem cell factor; OX40L, OX40 ligand; RANKL, receptor activator of NF-κB; TNF, tumor necrosis factor; TSLP, thymic stromal lymphopoietin; TWEAK, TNF-related weak inducer of apoptosis.